http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 622 reviews. 622 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Pantopra

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only.
You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Pantopra uses and description

Sort by popularity
Pantopra - Pantopra is a substituted benzimidazole indicated for the short-term treatment (up to 16 weeks) in the healing and symptomatic relief of erosive esophagitis. Pantopra is a proton pump inhibitor (PPI) that suppresses the final step in gastric acid production.

Pantopra is a gastric medicine. It is used to treat conditions caused by excessive acidity in your stomach, such as stomach ulcers and reflux disease (reflux is also known as "heartburn", in which food or acid from your stomach backs up into your mouth, leaving a sour or bitter taste). Pantopra treats these conditions by reducing the amount of acid your stomach makes. Pantopra may also be used together with other medicines to treat a specific type of gastric problem called Helicobacter pylori or H. pylori gastritis.

Oral Gastro-oesophageal reflux disease

Adult: 20-40 mg once daily in the morning for 4 wk, increased to 8 wk if necessary.

Maintenance: 20-40 mg daily, increased to 40 mg each morning if symptoms return. Hepatic impairment: Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral Peptic ulcer

Adult: 40 mg once daily in the morning for 2-4 wk for duodenal ulceration or 4-8 wk for benign gastric ulceration. Hepatic impairment: Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral H.pylori infection

Adult: Triple therapy: 40 mg bid combined with clarithromycin 500 mg bid and either amoxicillin 1 g bid or metronidazole 400 mg bid. Hepatic impairment: Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral Prophylaxis of NSAID-induced ulcers

Adult: 20 mg daily. Hepatic impairment: Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral Zollinger-Ellison syndrome

Adult: Initially 80 mg daily, adjusted to individual requirements. Up to 240 mg daily may be used if needed. Daily doses >80 mg should be given in 2 divided doses. Hepatic impairment: Doses >40 mg daily have not been studied in hepatically-impaired patients. Intravenous Zollinger-Ellison syndrome

Adult: As Na salt: 80 mg once or twice daily. Up to 240 mg daily may be given in divided doses. Convert to oral therapy as soon as possible. Dose to be given as slow inj or short-term infusion over 2-15 minutes. Hepatic impairment: May need to reduce dose. Intravenous Gastro-oesophageal reflux disease

Adult: As Na salt: 40 mg daily. Convert to oral therapy as soon as possible. Dose to be given as slow inj or short-term infusion over 2-15 minutes. Hepatic impairment: May need to reduce doses. Intravenous Peptic ulcer

Adult: As Na salt: 40 mg daily. Convert to oral therapy as soon as possible. Dose to be given as slow inj or short-term infusion over 2-15 minutes. Hepatic impairment: May need to reduce doses. Reconstitution: Reconstitute with 10 ml 0.9% sodium chloride (final concentration 4 mg/ml). Reconstituted solution may be given IV (over 2 minutes) or diluted to 100 ml in glucose 5%, 0.9% sodium chloride, or lactated Ringer's and infused over 15 min. Incompatibility: Y site incompatibility: midazolam and zinc.

Oral Gastro-oesophageal reflux disease

Adult: 20-40 mg once daily in the morning for 4 wk, increased to 8 wk if necessary.

Maintenance: 20-40 mg daily, increased to 40 mg each morning if symptoms return. Hepatic impairment: Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral Peptic ulcer

Adult: 40 mg once daily in the morning for 2-4 wk for duodenal ulceration or 4-8 wk for benign gastric ulceration. Hepatic impairment: Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral H.pylori infection

Adult: Triple therapy: 40 mg bid combined with clarithromycin 500 mg bid and either amoxicillin 1 g bid or metronidazole 400 mg bid. Hepatic impairment: Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral Prophylaxis of NSAID-induced ulcers

Adult: 20 mg daily. Hepatic impairment: Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral Zollinger-Ellison syndrome

Adult: Initially 80 mg daily, adjusted to individual requirements. Up to 240 mg daily may be used if needed. Daily doses >80 mg should be given in 2 divided doses. Hepatic impairment: Doses >40 mg daily have not been studied in hepatically-impaired patients. Intravenous Zollinger-Ellison syndrome

Adult: As Na salt: 80 mg once or twice daily. Up to 240 mg daily may be given in divided doses. Convert to oral therapy as soon as possible. Dose to be given as slow inj or short-term infusion over 2-15 minutes. Hepatic impairment: May need to reduce dose. Intravenous Gastro-oesophageal reflux disease

Adult: As Na salt: 40 mg daily. Convert to oral therapy as soon as possible. Dose to be given as slow inj or short-term infusion over 2-15 minutes. Hepatic impairment: May need to reduce doses. Intravenous Peptic ulcer

Adult: As Na salt: 40 mg daily. Convert to oral therapy as soon as possible. Dose to be given as slow inj or short-term infusion over 2-15 minutes. Hepatic impairment: May need to reduce doses. Special Populations: Reduce dose in patients with severe hepatic impairment or give only on alternate days. Max dose: 20 mg daily or 40 mg on alternate days. Reconstitution: Reconstitute with 10 ml 0.9% sodium chloride (final concentration 4 mg/ml). Reconstituted solution may be given IV (over 2 minutes) or diluted to 100 ml in glucose 5%, 0.9% sodium chloride, or lactated Ringer's and infused over 15 min. Incompatibility: Y site incompatibility: midazolam and zinc.

Indications:

Adult: PO GERD 20-40 mg /day in the morning for 4 wk, up to 8 wk if needed.

Maintenance: 20-40 mg/day. Peptic ulcer 40 mg/day in the morning. Duration: Duodenal ulceration: 2-4 wk; Benign gastric ulceration: 4-8 wk. H. pylori infection 40 mg twice daily w/ clarithromycin and either amoxicillin or metronidazole. Prevention of NSAID-induced ulcers 20 mg/day. Zollinger-Ellison syndrome and other hypersecretory states Initial: 80 mg/day. Max: 240 mg/day. IV Zollinger-Ellison syndrome and other hypersecretory states As Na salt: 80 mg/day. Max: 240 mg/day in divided doses if rapid control required. GERD; Peptic ulcer As Na salt: 40 mg/day until PO can be resumed.

Oral Gastroesophageal reflux disease with or without oesophagitis including erosions and ulcerations

Adult: 20-40 mg once daily in the morning for 4 wk, increased to 8 wk if necessary.

Maintenance: 20-40 mg daily, increased to 40 mg each morning if symptoms return. Hepatic impairment: No dosage adjustment is needed in mild to severe impairment. Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral Peptic ulcer

Adult: 40 mg once daily in the morning for 2-4 wk for duodenal ulceration or 4-8 wk for benign gastric ulceration. Hepatic impairment: No dosage adjustment is needed in mild to severe impairment. Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral Eradication of H. pylori infection

Adult: Triple therapy: 40 mg bid combined with clarithromycin 500 mg bid and either amoxicillin 1 g bid or metronidazole 400 mg bid. Hepatic impairment: No dosage adjustment is needed in mild to severe impairment. Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral Prophylaxis of NSAID associated peptic ulcer

Adult: 20 mg daily. Hepatic impairment: No dosage adjustment is needed in mild to severe impairment. Doses >40 mg daily have not been studied in hepatically-impaired patients. Oral Zollinger-Ellison syndrome and other hypersecretory states

Adult: Initially 80 mg daily, adjusted to individual requirements. Max daily dose: 240 mg daily. Daily doses >80 mg should be given in 2 divided doses. Hepatic impairment: No dosage adjustment is needed in mild to severe impairment. Doses >40 mg daily have not been studied in hepatically-impaired patients. Intravenous Zollinger-Ellison syndrome and other hypersecretory states

Adult: 80 mg (as the sodium salt) daily over 2-15 min. Max dose: 240 mg daily in divided doses if rapid control required. Hepatic impairment: No dosage adjustment is needed in mild to severe impairment. Doses >40 mg daily have not been studied in hepatically-impaired patients. Intravenous Peptic ulcer

Adult: 40 mg (as the sodium salt) daily (over 2-15 min) until oral administration can be resumed. Hepatic impairment: No dosage adjustment is needed in mild to severe impairment. Doses >40 mg daily have not been studied in hepatically-impaired patients. Intravenous Gastroesophageal reflux disease with or without oesophagitis including erosions and ulcerations

Adult: 40 mg (as the sodium salt) daily (over 2-15 min) until oral administration can be resumed. Hepatic impairment: No dosage adjustment is needed in mild to severe impairment. Doses >40 mg daily have not been studied in hepatically-impaired patients. Reconstitution: Reconstitute with 10 ml 0.9% sodium chloride (final concentration 4 mg/ml). Reconstituted solution may be given IV (over 2 minutes) or diluted to 100 ml in glucose 5%, 0.9% sodium chloride, or lactated Ringer's and infused over 15 min. Incompatibility: Y site incompatibility: midazolam and zinc.

Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD)Maintenance of Healing of Erosive EsophagitisPathologica Hypersecretory Conditions Including Zollinger-Ellison Syndrome

Active ingredients: Pantoprazole
Unit description, dosagePrice, USD

List of pantopra brand and generic drugs

PANTOPIK (India)
Pantopik 40mg TAB / 10$ 0.89
Pantopra-Q (Germany)
Pantopraz (Philippines)
Pantopraz 40 mg x 14's
Pantoprazol (India, Netherlands, Vietnam)
Injectable; Subcutaneous; Pantoprazole Sodium Sesquihydrate 40 mg
Tablet, Gastro-Resistant; Oral; Pantoprazole Sodium Sesquihydrate 20 mg
Tablet, Gastro-Resistant; Oral; Pantoprazole Sodium Sesquihydrate 40 mg
Pantoprazol +pharma (Czech Republic)
Pantoprazol AAA (Germany)
Pantoprazol AbZ (Germany)
Pantoprazol Accord (Spain)
Pantoprazol acis (Germany)
Pantoprazol Actavis (Austria, Germany, Slovakia, Sweden)
Pantoprazol Actavis Medis (Switzerland)
Pantoprazol AL (Germany)
Pantoprazol Almus (Spain)
Pantoprazol Alter (Spain)
Pantoprazol Alternova (Austria)
Pantoprazol antacid Sandoz (Switzerland)
Pantoprazol Apotex (Netherlands, Spain)
Pantoprazol Arcana (Austria)
Pantoprazol Aristo (Germany)
Pantoprazol Atid (Germany)
Pantoprazol Axapharm (Switzerland)
Pantoprazol Basi (Portugal)
Pantoprazol Basics (Germany)
Pantoprazol beta (Germany)
Pantoprazol Bexal (Spain)
Pantoprazol Billix (Germany)
Pantoprazol biomo (Germany)
Pantoprazol Bluefish (Spain)
Pantoprazol Braiter (Portugal)
Pantoprazol Byk (Netherlands)
Pantoprazol Calox (Venezuela)
Pantoprazol CF (Netherlands)
Pantoprazol Cinfa (Spain)
Pantoprazol Citrel (Spain)
Pantoprazol Combino Pharm (Spain)
Pantoprazol Combix (Spain)
Pantoprazol Combuxim (Spain)
Pantoprazol CT (Germany)
Pantoprazol Davur (Spain)
Pantoprazol DOMESCO (Vietnam)
Pantoprazol DOMESCO 40 mg x 1 Blister x 14 Tablet

Show all Pantopra generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer